blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2622088

EP2622088 - MANNOSIDASES CAPABLE OF UNCAPPING MANNOSE-1-PHOSPHO-6-MANNOSE LINKAGES AND DEMANNOSYLATING PHOSPHORYLATED N-GLYCANS AND METHODS OF FACILITATING MAMMALIAN CELLULAR UPTAKE OF GLYCOPROTEINS [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  28.07.2017
Database last updated on 30.10.2024
Most recent event   Tooltip23.02.2024Change - applicantpublished on 27.03.2024  [2024/13]
Applicant(s)For all designated states
Oxyrane UK Limited
83 Ducie Street
Manchester M1 2JQ / GB
[2024/13]
Former [2014/47]For all designated states
Oxyrane UK Limited
Suite 313, Piccadilly House
49 Piccadilly
Manchester M1 2AP / GB
Former [2013/32]For all designated states
Oxyrane UK Limited
Greenheys House Manchester Science Park 10 Pencroft Way
Manchester M15 6JJ / GB
Inventor(s)01 / NOELLA, Gwenda, Pynaert
Riethulstraat 7
B-9880 Aalter / BE
02 / PIENS, Kathleen Camilla, Telesphore Alida Maria
Citadellaan 54
B-9000 Gent / BE
03 / VALEVSKA, Albena, Vergilieva
Maaltebruggestraat 197
B-9000 Gent / BE
04 / VERVECKEN, Wouter
Edmond Van Hoorebekestraat 90
B-9050 Gent-ledeberg / BE
 [2013/32]
Representative(s)Michalík, Andrej, et al
De Clercq & Partners cvba Edgard Gevaertdreef 10 a
9830 Sint-Martens-Latem / BE
[2014/36]
Former [2013/32]White, Martin Paul
Whites IP Ltd
7 Berwick Road
Bournemouth
BH3 7BB / GB
Application number, filing date11796810.729.09.2011
WO2011IB02770
Priority number, dateUS201161477014P19.04.2011         Original published format: US 201161477014 P
US20100387940P29.09.2010         Original published format: US 387940 P
[2013/32]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2012042386
Date:05.04.2012
Language:EN
[2012/14]
Type: A2 Application without search report 
No.:EP2622088
Date:07.08.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 05.04.2012 takes the place of the publication of the European patent application.
[2013/32]
Search report(s)International search report - published on:EP31.05.2012
ClassificationIPC:C12P19/26, C12P21/00, A61K38/43, C12N9/10, C12N15/81
[2013/32]
CPC:
C12P21/005 (EP,US); C12P19/26 (KR); A61K38/16 (EP,US);
A61K38/1709 (EP,US); A61K38/43 (KR); A61P43/00 (EP);
C12N9/10 (KR); C12N9/2402 (EP,US); C12N9/2488 (EP,US);
C12P21/00 (KR); C12Y302/01024 (EP,US); A61K38/00 (EP,US);
C12Y302/01 (EP,US); Y02P20/52 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/32]
TitleGerman:MANNOSIDASEN ZUM ENTKAPPEN VON MANNOSE-1-PHOSPHO-6-MANNOSE-BINDUNGEN UND DEMANNOSYLIERUNG VON PHOSPHORYLIERTEN N-GLYKANEN SOWIE VERFAHREN ZUR ERMÖGLICHUNG DER ZELLULÄREN AUFNAHME VON GLYKOPROTEINEN DURCH SÄUGERZELLEN[2013/32]
English:MANNOSIDASES CAPABLE OF UNCAPPING MANNOSE-1-PHOSPHO-6-MANNOSE LINKAGES AND DEMANNOSYLATING PHOSPHORYLATED N-GLYCANS AND METHODS OF FACILITATING MAMMALIAN CELLULAR UPTAKE OF GLYCOPROTEINS[2013/32]
French:MANNOSIDASES CAPABLES D'ÉLIMINER LA COIFFE DES LIAISONS MANNOSE-1-PHOSPHO- 6-MANNOSE ET DE DÉMANNOSYLER LES N-GLYCANES PHOSPHORYLÉS, ET MÉTHODES FACILITANT L'ASSIMILATION DES GLYCOPROTÉINES PAR DES CELLULES DE MAMMIFÈRES[2013/32]
Entry into regional phase26.04.2013National basic fee paid 
26.04.2013Designation fee(s) paid 
26.04.2013Examination fee paid 
Examination procedure30.07.2012Request for preliminary examination filed
International Preliminary Examining Authority: EP
26.04.2013Examination requested  [2013/32]
29.11.2013Amendment by applicant (claims and/or description)
27.07.2017Despatch of a communication from the examining division (Time limit: M06)
30.01.2018Reply to a communication from the examining division
22.05.2019Despatch of a communication from the examining division (Time limit: M06)
26.11.2019Reply to a communication from the examining division
17.03.2021Despatch of a communication from the examining division (Time limit: M06)
22.09.2021Reply to a communication from the examining division
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  27.07.2017
Fees paidRenewal fee
27.09.2013Renewal fee patent year 03
01.08.2014Renewal fee patent year 04
25.09.2015Renewal fee patent year 05
22.09.2016Renewal fee patent year 06
26.09.2017Renewal fee patent year 07
25.09.2018Renewal fee patent year 08
24.09.2019Renewal fee patent year 09
24.09.2020Renewal fee patent year 10
22.09.2021Renewal fee patent year 11
27.09.2022Renewal fee patent year 12
26.09.2023Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY]EP1408117  (NAT INST OF ADVANCED IND SCIEN [JP], et al) [X] 1-4,6-8,15,22,23,29,31-33,35-52 * page 4, paragraph [0021] - page 9, paragraph [0027] * * page 12, paragraphs [0051]-[0052]; examples 1,2,4,6 * [Y] 3-5,9-14,16-21,24-28,30,34;
 [XY]WO2004074498  (HAMILTON STEPHEN R [US], et al) [X] 1,2,43-48,57,58 * page 10, paragraph [0021] - page 11, paragraph [0023] * * page 12, paragraph [0025] - page 13, paragraph [0028] * * page 17, paragraph [0040] - page 22, paragraph [0066] * * page 45, paragraph [0162] - page 54, paragraph [186] * * page 91, paragraph [568] - page 94, paragraph [577] * * page 118, paragraph [0635] - page 120, paragraph [637]; table 6 * * examples 1,2,6,8,9,17-23 * [Y] 3,9,11,16,18,20,24,27;
 [XY]WO2008120107  (OXYRANE UK LTD [GB], et al) [X] 43-58 * page 1, line 19 - page 2, line 7 * * page 2, line 19 - page 3, line 30 * * page 4, lines 7-27 * * page 5, lines 15-18 * * page 7, lines 19-24 * * page 26, line 20 - page 28, line 15 * * page 37, line 26 - page 38, line 3; examples 2-4,11-13,15-16 * [Y] 3-5,9-14,16-21,24-28,30,34;
 [XP]WO2011039634  (UNIV GENT [BE], et al) [XP] 1-58* the whole document *;
 [XY]  - CHIBA YASUNORI ET AL, "Production in yeast of alpha-galactosidase A, a lysosomal enzyme applicable to enzyme replacement therapy for Fabry disease", GLYCOBIOLOGY, OXFORD UNIVERSITY PRESS, US, (20021201), vol. 12, no. 12, doi:10.1093/GLYCOB/CWF096, ISSN 0959-6658, pages 821 - 828, XP002509578 [X] 1,2,4,6-8,15,22,23,29,31-33,35-52 * abstract * * page 821, column r, paragraph l - page 826, column l, paragraph 1 * [Y] 3-5,9-14,16-21,24-28,30,34

DOI:   http://dx.doi.org/10.1093/glycob/cwf096
 [Y]  - MERKLE R K ET AL, "Cloning, expression, purification, and characterization of the murine lysosomal acid alpha-mannosidase", BIOCHIMICA ET BIOPHYSICA ACTA - GENERAL SUBJECTS, ELSEVIER SCIENCE PUBLISHERS, NL, (19970827), vol. 1336, no. 2, doi:10.1016/S0304-4165(97)00023-8, ISSN 0304-4165, pages 132 - 146, XP004276600 [Y] 3-5,9-14,16-21,24-28,30,34 * abstract * * page 132, column r, paragraph 1 - page 133, column r, paragraph 2 * * page 142, column l, paragraph 2 - page 143, column r, paragraph 1 *

DOI:   http://dx.doi.org/10.1016/S0304-4165(97)00023-8
 [Y]  - VANDERSALL-NAIRN AS ET AL, "Cloning, expression, purification, and characterization of the acid alpha-mannosidase from Trypanosoma cruzi", GLYCOBIOLOGY, OXFORD UNIVERSITY PRESS, US, (19981201), vol. 8, no. 12, doi:10.1093/GLYCOB/8.12.1183, ISSN 0959-6658, pages 1183 - 1194, XP002628928 [Y] 3-5,9-14,16-21,24-28,30,34 * page 1183, column l, paragraph l - column r, paragraph 3 * * page 1186, column l, paragraph l - page 1187, column r, paragraph 2 *

DOI:   http://dx.doi.org/10.1093/glycob/8.12.1183
 [Y]  - LIAO Y-F ET AL, "CLONING, EXPRESSION, PURIFICATION, AND CHARACTERIZATION OF THE HUMAN BROAD SPECIFICITY LYSOSOMAL ACID ALPHA-MANNOSIDASE", JOURNAL OF BIOLOGICAL CHEMISTRY, THE AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, INC, US, (19961108), vol. 271, no. 45, doi:10.1074/JBC.271.20.11838, ISSN 0021-9258, pages 28348 - 28358, XP001118202 [Y] 3-5,9-14,16-21,24-28,30,34 * abstract * * page 28353, column r, paragraph l - page 28354, column r, paragraph 1 *

DOI:   http://dx.doi.org/10.1074/jbc.271.20.11838
 [Y]  - GONZALEZ DANIEL S ET AL, "The alpha-mannosidases: Phylogeny and adaptive diversification", MOLECULAR BIOLOGY AND EVOLUTION, THE UNIVERSITY OF CHICAGO PRESS, US, (20000201), vol. 17, no. 2, ISSN 0737-4038, pages 292 - 300, XP002293609 [Y] 3-5,9-14,16-21,24-28,30,34 * page 293, column r, paragraph 2 * * page 294, column r, paragraph 2 - page 296, column r, paragraph 1; figures 1,2 *
 [Y]  - MARTINET W ET AL, "Protection of mice against a lethal influenza challenge by immunization with yeast-derived recombinant influenza neuraminidase", EUROPEAN JOURNAL OF BIOCHEMISTRY 1997 DE, (1997), vol. 247, no. 1, ISSN 0014-2956, pages 332 - 338, XP002671071 [Y] 3,4,9,11,16,18,20,24,27 * abstract * * page 333, column r, paragraph 3 * * page 335, column l, paragraph l *

DOI:   http://dx.doi.org/10.1111/j.1432-1033.1997.00332.x
Examination   - Anonymous, "CAZy - GH38", (20190516), pages 1 - 5, URL: http://www.cazy.org/GH38_characterized.html, (20190516), XP055589554
    - ICHISHIMA EIJI ET AL, "Molecular and enzymic properties of recombinant 1,2-alpha-mannosidase from Aspergillus saitoi overexpressed in Aspergillus oryzae cells", 19990501, (19990501), vol. 339, no. 3, pages 589 - 597, XP002353325
by applicantUS4307717
 US4352883
 US4353888
 US4407957
 US4704362
 US4837148
 US4879231
 US4882279
 US4883666
 US4929555
 US4968733
 US4976859
 US5084350
 US5158881
 WO9219195
 US5284761
 WO9505452
 US5798113
 US5800828
 US6265185
 US2006014264
 WO2011039634
    - Current Protocols in Molecular Biology, JOHN WILEY & SONS, (1991), pages 6.3.1 - 6.3.6
    - HOWARD ET AL., J. BIOL. CHEM., (1998), vol. 273, no. 4, pages 2067 - 2072
    - BURTON; HARDING, J. CHROMATOGR. A, (1998), vol. 814, pages 71 - 81
    - MOREAU ET AL., J. BIOL. CHEM., (1991), vol. 266, no. 7, pages 4329 - 4333
    - MOREAU ET AL., J. BIOL. CHEM., (1991), vol. 266, no. 7, pages 4322 - 4328
    - REXACH ET AL., J. CELL BIOL., (1991), vol. 114, no. 2, pages 219 - 229
    - PAULIK ET AL., ARCH. BIOCHEM. BIOPHYS., (1999), vol. 367, no. 2, pages 265 - 273
    - HENDERSON; FINN, ADVANCES IN IMMUNOLOGY, (1996), vol. 62, pages 217 - 256
    - NEWMAN; FERRO-NOVICK, J. CELL BIOL., (1987), vol. 105, no. 4, page 1587
    - GUARENTE ET AL., PROC. NATL. ACAD. SCI. USA, (1982), vol. 79, no. 23, page 7410
    - ZHU; ZHANG, BIOINFORMATICS, (1999), vol. 15, no. 7-8, pages 608 - 611
    - GOSSEN ET AL., ANN. REV. GENETICS, (2002), vol. 3 6, pages 153 - 173
    - HINNEN ET AL., PROC. NAT. ACAD. SCI. USA, (1978), vol. 75, page 1929
    - ITO ET AL., J. BACTERIOL., (1983), vol. 153, page 163
    - SREEKRISHNA ET AL., GENE, (1987), vol. 59, page 115
    - CREGG; RUSSEL, Methods in Molecular Biology: Pichia Protocols, HUMANA PRESS, (1998), pages 27 - 39
    - CALLEWAERT ET AL., GLYCOBIOLOGY, (2001), vol. 11, no. 4, pages 275 - 281
    - FREIRE ET AL., BIOCONJUG. CHEM., (2006), vol. 17, no. 2, pages 559 - 564
    - Remington's Pharmaceutical Sciences, MAACK PUBLISHING CO.
    - ANNALS OF PHARMACOTHERAPY, (1993), vol. 27, page 912
    - CANCER, (1993), vol. 41, page 1270
    - CANCER RESEARCH, (1984), vol. 44, page 1698
    - LAROY ET AL., NATURE PROTOCOLS, (2006), vol. 1, pages 397 - 405
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.